 |
|
Morphine: a comfort measure for the dying or pain control for the living?
December 11, 2007Cancer patients are suffering unnecessarily because they wrongly believe that morphine and other opioids are only used as "comfort for the dying" and as a "last resort" rather than seeing them as legitimate pain killers that can improve their quality of life.
In a study published online today (Tuesday 11 December) in the cancer journal, Annals of Oncology [1], experts in palliative care also say "the belief that opioids hasten death is widely held" amongst patients and this "has a significant impact on pain management, as patients felt that an offer of opioids signified imminent death". Previous studies have estimated that between 40-70% of cancer patients may not have their pain properly controlled with the right medication for a variety of reasons.
Dr Colette Reid, the lead author of the study, said: "If we are to employ the range of available opioids in order to successfully manage pain caused by cancer, we must ensure that morphine does not remain inextricably linked with death. If this connection stays in place then morphine will continue to be viewed as a comfort measure for the dying rather than a means of pain control for the living."
Dr Reid, a consultant in palliative medicine at the Gloucester Royal Hospital, Gloucester, UK, conducted in-depth interviews with 18 patients with metastatic cancer, aged between 55 and 82, who were asked to take part in a cancer pain management trial. She wanted to examine how patients reacted when first offered an opioid drug described as similar to morphine. Dr Reid also wanted to understand the factors that influenced patients' decisions whether to accept or to reject morphine. The interviews were analysed along with an experienced social scientist Rachael Gooberman-Hill, and Geoffrey Hanks, professor of palliative medicine, both from the University of Bristol.
The patients interviewed were all white and half of them were women. Their views and experiences about morphine fell into four distinct but inter-related categories: anticipation of death, morphine as a last resort, the role of the professional, and no choice but to commence.
Morphine as a "last resort" was the central theme to emerge from the interviews. The authors write: "We found that patients with cancer who were offered morphine for pain relief interpreted this as a signal that their health professional thought they were dying, because opioids were interventions used only as a 'last resort'. Because participants themselves were not ready to die, they rejected morphine and other opioids as analgesics, despite the pain experienced as a consequence. Participants' descriptions of the role of professionals indicated that patients value professionals' confidence in opioids. Some patients may therefore become more frightened when offered a choice, since this indicates a lack of confidence in the opioid as an analgesic."
It could be argued that the patients' belief that the use of morphine represented a ramping up of treatment in the face of approaching death and the associated pain is a reasonably held view, especially as most of the patients interviewed for the study have subsequently died.
However, Dr Reid said: "The World Health Organization guidelines for the management of cancer pain state that analgesic treatment choices should be based on the severity of the pain, not on prognosis. So patients at all stages of cancer could have morphine if their pain is sufficient. In reality, the patients most likely to experience pain, and likely also to have the most severe pain, are those with metastatic disease, i.e. their cancer cannot be cured. These patients may yet have many months to live, but their quality of life is adversely affected by pain, since unrelieved pain leads to social isolation, loss of role and depressed mood. This was the group of patients that we interviewed - patients with metastatic disease and life expectancy measured in months.
"The fear of these patients was that morphine suggested imminent death (and also possibly hastened death) and that once commenced would mean that they would not be able to function normally. However, morphine if used properly, can actually promote quality of life by allowing patients with pain to function better."
Dr Reid and her colleagues say that the role of the medical professional is crucial in helping to change patients' beliefs and attitudes towards morphine. They write that the study's findings "highlight the importance of the professional in cancer pain management, but also how beliefs about opioids that are communicated to the relatives of the dying may have implications for the pain relief of others in the future".
Dr Reid said: "During the interviews, patients told us that that when a professional had been confident about opioids, then this had made them feel more able to accept the possibility of taking opioid medication. However, the main source of their fears was either personal experience or stories told by others. If more patients had good experiences with morphine (and other opioids) then the stories will be more reassuring."
She continued: "Our interviews suggested to us that the patients detected professional ambivalence towards morphine and so this heightened their fears. They also told us that professionals had worried, incorrectly, about hastening death by using morphine and had communicated this fear to relatives. We are getting better at educating medical students about opioids and pain management, but another study we are involved in at the moment suggests that there are definitely educational needs for professionals. I think the role of palliative care teams is crucial here, since we can educate both professionals and patients."
In an accompanying editorial [2], Dr Marco Maltoni, head of the Palliative Care Unit, Forlì Local Health Authority and Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Meldola, Italy, agrees. He writes: "Professional competence, correct communication, and a relationship based on trust are the three principle factors taken into consideration by patients when deciding whether or not to start opioid treatment."
He concludes that the study "which originates from the birthplace of palliative care, is somewhat disturbing in the messages it conveys - extreme fear of opioids and high barriers to palliative care strategies. It suggests that a great many years of health education have not produced the results that might have been hoped for. The problem remains that a number of oncologists today still tend to reserve the use of opioids for the final stages of the disease. A vision of pain management and palliative care that is not solely linked to the end-of-life but rather seen as a positive option, in the less advanced stage of disease as well, needs to be promoted."
[1] Opioid analgesics for cancer pain: symptom control for the living or comfort for the dying" A qualitative study to investigate the factors influencing the decision to accept morphine for pain caused by cancer. Annals of Oncology. doi:10.1093/annonc/mdm462.
[2] Opioids, pain and fear. Annals of Oncology. doi:10.1093/annonc/mdm555
European Society for Medical Oncology
Dr Reid, a consultant in palliative medicine at the Gloucester Royal Hospital, Gloucester, UK, conducted in-depth interviews with 18 patients with metastatic cancer, aged between 55 and 82, who were asked to take part in a cancer pain management trial. She wanted to examine how patients reacted when first offered an opioid drug described as similar to morphine. Dr Reid also wanted to understand the factors that influenced patients' decisions whether to accept or to reject morphine. The interviews were analysed along with an experienced social scientist Rachael Gooberman-Hill, and Geoffrey Hanks, professor of palliative medicine, both from the University of Bristol.
The patients interviewed were all white and half of them were women. Their views and experiences about morphine fell into four distinct but inter-related categories: anticipation of death, morphine as a last resort, the role of the professional, and no choice but to commence.
Morphine as a "last resort" was the central theme to emerge from the interviews. The authors write: "We found that patients with cancer who were offered morphine for pain relief interpreted this as a signal that their health professional thought they were dying, because opioids were interventions used only as a 'last resort'. Because participants themselves were not ready to die, they rejected morphine and other opioids as analgesics, despite the pain experienced as a consequence. Participants' descriptions of the role of professionals indicated that patients value professionals' confidence in opioids. Some patients may therefore become more frightened when offered a choice, since this indicates a lack of confidence in the opioid as an analgesic."
It could be argued that the patients' belief that the use of morphine represented a ramping up of treatment in the face of approaching death and the associated pain is a reasonably held view, especially as most of the patients interviewed for the study have subsequently died.
However, Dr Reid said: "The World Health Organization guidelines for the management of cancer pain state that analgesic treatment choices should be based on the severity of the pain, not on prognosis. So patients at all stages of cancer could have morphine if their pain is sufficient. In reality, the patients most likely to experience pain, and likely also to have the most severe pain, are those with metastatic disease, i.e. their cancer cannot be cured. These patients may yet have many months to live, but their quality of life is adversely affected by pain, since unrelieved pain leads to social isolation, loss of role and depressed mood. This was the group of patients that we interviewed - patients with metastatic disease and life expectancy measured in months.
"The fear of these patients was that morphine suggested imminent death (and also possibly hastened death) and that once commenced would mean that they would not be able to function normally. However, morphine if used properly, can actually promote quality of life by allowing patients with pain to function better."
Dr Reid and her colleagues say that the role of the medical professional is crucial in helping to change patients' beliefs and attitudes towards morphine. They write that the study's findings "highlight the importance of the professional in cancer pain management, but also how beliefs about opioids that are communicated to the relatives of the dying may have implications for the pain relief of others in the future".
Dr Reid said: "During the interviews, patients told us that that when a professional had been confident about opioids, then this had made them feel more able to accept the possibility of taking opioid medication. However, the main source of their fears was either personal experience or stories told by others. If more patients had good experiences with morphine (and other opioids) then the stories will be more reassuring."
She continued: "Our interviews suggested to us that the patients detected professional ambivalence towards morphine and so this heightened their fears. They also told us that professionals had worried, incorrectly, about hastening death by using morphine and had communicated this fear to relatives. We are getting better at educating medical students about opioids and pain management, but another study we are involved in at the moment suggests that there are definitely educational needs for professionals. I think the role of palliative care teams is crucial here, since we can educate both professionals and patients."
In an accompanying editorial [2], Dr Marco Maltoni, head of the Palliative Care Unit, Forlì Local Health Authority and Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Meldola, Italy, agrees. He writes: "Professional competence, correct communication, and a relationship based on trust are the three principle factors taken into consideration by patients when deciding whether or not to start opioid treatment."
He concludes that the study "which originates from the birthplace of palliative care, is somewhat disturbing in the messages it conveys - extreme fear of opioids and high barriers to palliative care strategies. It suggests that a great many years of health education have not produced the results that might have been hoped for. The problem remains that a number of oncologists today still tend to reserve the use of opioids for the final stages of the disease. A vision of pain management and palliative care that is not solely linked to the end-of-life but rather seen as a positive option, in the less advanced stage of disease as well, needs to be promoted."
[1] Opioid analgesics for cancer pain: symptom control for the living or comfort for the dying" A qualitative study to investigate the factors influencing the decision to accept morphine for pain caused by cancer. Annals of Oncology. doi:10.1093/annonc/mdm462.
[2] Opioids, pain and fear. Annals of Oncology. doi:10.1093/annonc/mdm555
European Society for Medical Oncology
Morphine Current Events and Morphine News RSSChronic pain treatments work better together, says Queen's anesthesiologist
People who suffer from debilitating neuropathic pain may get more relief and sleep better by combining two commonly-prescribed drugs.
Infant pain, adult repercussions
Scientists at Georgia State University have uncovered the mechanisms of how pain in infancy alters how the brain processes pain in adulthood.
Nanoparticle-based battlefield pain treatment moves step closer
University of Michigan scientists have developed a combination drug that promises a safer, more precise way for medics and fellow soldiers in battle situations to give a fallen soldier both morphine and a drug that limits morphine's dangerous side effects.
Researchers explore long-term adolescent vulnerability to drugs
As part of efforts to understand drug abuse, Georgia State University researchers are finding that adolescent rats appear to be less vulnerable to the long-term effects of withdrawal and relapse in certain types of drug use than rats that take the drugs in adulthood.
Researchers find genetic link between physical pain and social rejection
UCLA psychologists have determined for the first time that a gene linked with physical pain sensitivity is associated with social pain sensitivity as well.
Chinese acupuncture affects brain's ability to regulate pain, UM study shows
Acupuncture has been used in East-Asian medicine for thousands of years to treat pain, possibly by activating the body's natural painkillers. But how it works at the cellular level is largely unknown.
Fish may actually feel pain and react to it much like humans
Fish don't make noises or contort their faces to show that it hurts when hooks are pulled from their mouths, but a Purdue University researcher believes they feel that pain all the same.
Hebrew University researchers show how morphine can be given more effectively
Researchers at the Hebrew University of Jerusalem have found a way to maintain the pain-killing qualities of morphine over an extended period of time, thus providing a solution for the problem of having to administer increasing dosages of the drug in order to retain its effectiveness.
Mayo Clinic study suggests those who have chronic pain may need to assess vitamin D status
Mayo Clinic research shows a correlation between inadequate vitamin D levels and the amount of narcotic medication taken by patients who have chronic pain.
New guidelines for prescribing opioid pain drugs published
A prestigious panel of pain-management experts representing the American Pain Society (APS) www.ampainsoc.org and the American Academy of Pain Medicine (AAPM) has published the first comprehensive clinical practice guideline to assist clinicians in prescribing potent opioid pain medications for patients with chronic non-cancer pain.
More Morphine Current Events and Morphine News Articles
 |
At Your Service by Morphine Singer Mark Sandman coined the phrase "low rock" to describe the sonorous, languid groove he created with the acclaimed Boston band Morphine. This 34 song, two-disc collection contains all previously unissued studio tracks, alternate takes, and live performances, and takesits name from the line Sandman used to kick off most shows, "We are Morphine at your service." The music spans the group's entire career and features founding members Sandman (two-string slide bass, vocals),Dana Colley (saxophone), original drummer Jerome Deupree, and his successor, Billy Conway. |
 |
Cure for Pain by Morphine Cure for Pain is a most unlikely artistic breakthrough from a thoroughly unlikely band. Fronted by saxophone and two-string slide bass guitar, Morphine earned a modicum of critical praise for their prior recording, Good, but Cure for Pain has a harder edge and a distinctly bigger sound. "Buena" urges the listener, with singer and bassist Mark Sandman's best come-hither baritone voice, "closer to the front of the stage," and then "Candy" tells a love-lost story that could come right out of Tom Waits's book. But for all the strange possibilities inherent in a guitarless band that plays off their singer's wry lyrics, Morphine's sophomore effort shows their versatility, their ability to be a rock band in a very unrock, rolling-baritone-saxophone way. Alas, singer Mark Sandman perished in... |
 |
At Your Service (Amazon MP3 Exclusive Version) Morphine (Primary Contributor) |
 |
The Night by Morphine Singer-bassist-frontman Mark Sandman died July 3, 1999, onstage just outside Rome doing what he loved most. While it was never intended as a swan song, The Night, Morphine's fifth official studio album (not counting a B-sides collection or a projected live album), has all the dramatic hallmarks of a long, permanent goodbye. The band's "low-rock"--of bass, baritone sax, drums, and Sandman's own Leonard Cohen-afterworld vocals--always had a finality about it. The serious mix of blues fatalism and muted jazz hysteria filtered through the downbeat world of Tom Waits ("Like a Mirror" is gift-wrapped in his image) and other lingering beatniks always means it's 3 a.m. in Sandman's gypsy soul. The title track, "Top Floor, Bottom Buzzer," and "Rope on Fire" will stand among the finest in... |
 |
Like Swimming by Morphine Morphine's music, which connects with listeners on a very physical level, is so simple it's amazing no one's done it before. Using exclusively low-register instruments, Mark Sandman's two-string bass and baritone voice, and Dana Colley's bass and baritone saxophones, the band's songs actually reverberate in the chest, treating listeners to a low-impact massage. And anything that feels this good can't be bad. But Morphine's blessing--that distinctive low rock sound--is also their curse. Not only do they bind themselves to an instantly recognizable sound, but they also limit themselves in their arrangements: Voice and sax can each hit only one note at a time (though Colley sometimes manages to honk two saxes at once), while the bass can manage a two-note interval at best. It's hard being... |
 |
Yes by Morphine Originally released in 1995, Yes was Boston-based trio Morphine's third album. Featuring Mark Sandman on vocals and slide bass, Dana Colley on baritone sax, and Billy Conway on drums, Yes hit #1 on Billboard's Top Heatseekers chart, expanding the group's substantial cult following and the appeal of their noirish, guitar free, "low rock" sonics. Critical acclaim for the album and stand-out tracks, including singles "Honey White" and Super Sex," paved the way for Morphine's major label deal the following year. The new audiophile reissue of this alt-rock classic pressed on 180-gram vinyl. |
 |
Good by Morphine With no guitars and a half a set of bass strings, Morphine managed to rock harder than most of their fret-bound competition while retaining the slippery nocturnal undercurrent that would become their signature sound. On this 1992 debut album, the Boston trio strips down the minor-key blues of frontman Mark Sandman's former group, Treat Her Right, and adds a host of off-kilter elements. Sandman's slide bass and narcoleptic vocals are perfectly complemented by Dana Colley's frenetic baritone sax, which he plays like a cross between Rahsaan Roland Kirk and Van Der Graaf Generator's David Jackson. Sandman reportedly played one-string bass for this album (he'd later expand to two), and the sound quality here is murkier than on subsequent efforts. But tracks such as the infectious "You Speak My... |
 |
Cure For Pain Morphine (Primary Contributor) |
 |
Best of 1992-1995 by Morphine 2003 compilation chronicles the band's recorded output for Rykodisc & includes three previously unreleased compositions as well as an enhanced video of 'Shame' recorded live on tour in Atlanta. |
 |
B-Sides & Otherwise by Morphine |
| © 2009 BrightSurf.com |